Giulia Bertorelli
Head of Cardiometabolic Marketing (interim), Region EUCAN at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark
Giulia Bertorelli’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Head of Cardiometabolic Marketing (interim), Region EUCAN at Novo Nordisk in March 2026 - Present
Commercial Director, Cardiometabolic Marketing, Region EUCAN at Novo Nordisk in May 2025 - February 2026
Global Associate Director, Device Strategy and Marketing at Novo Nordisk in April 2024 - May 2025
Global Device Lead, Device Strategy and Marketing at Novo Nordisk in March 2023 - March 2024
Director, Product Category Management, OEM Partnerships at Arjo in March 2021 - February 2023
Senior Manager, Corporate Development at Arjo in October 2018 - February 2021
Manager, Corporate Development at Arjo in May 2017 - September 2018
Associate, Business Development at Arla Foods in September 2016 - April 2017
Getinge Group in Thailand - Master Thesis Project at Getinge in June 2016 - July 2016
Business Project CEMS at GE in March 2016 - May 2016
Student Assistant, Business Strategy at Arjo in October 2014 - December 2015
Event Hostess at Centro Internazionale Guida Sicura in May 2013 - July 2014
CEMS - The Global Alliance in Management Education, Master in International Management, November 2026
FGV - Fundação Getulio Vargas, CEMS - The Global Alliance in Management, November 2026
Copenhagen Business School, Master of Science (MSc), November 2026
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Giulia Bertorelli email address?
Email Giulia Bertorelli at [email protected], [email protected] and [email protected]. This email is the most updated Giulia Bertorelli's email found in 2026.
What is Giulia Bertorelli phone number?
Giulia Bertorelli phone number is +4553822762.
How to contact Giulia Bertorelli?
To contact Giulia Bertorelli send an email to [email protected], [email protected] or [email protected]. If you want to call Giulia Bertorelli try calling on +4553822762. (updated on April 18, 2026)
What company does Giulia Bertorelli work for?
Giulia Bertorelli works for Novo Nordisk.
What is Giulia Bertorelli's role at Novo Nordisk?
Giulia Bertorelli is Head of Cardiometabolic Marketing (interim), Region EUCAN
What industry does Giulia Bertorelli work in?
Giulia Bertorelli works in the Pharmaceuticals industry.
